Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Claudia A. van Winkel"'
Autor:
Claudia A. van Winkel, Xiaoyu Fan, Danique Giesen, Glenn Gauderat, Lucia Pattarini, Thomas Jaquin, Anissa Barakat, Anne-Marie De La Bigne, Marleen Richter, Nicole Andersen, Julie Legrand, Helene Lelièvre, Elisabeth G. de Vries, Aizea Morales-Kastresana, Marjolijn N. Lub- de Hooge
Publikováno v:
Cancer Research. 83:3579-3579
Background: PRS-344/S095012 is a novel 4-1BB (CD137) and programmed death-ligand 1 (PD-L1) bispecific antibody-Anticalin® fusion protein (MabcalinTM protein) designed to cluster 4-1BB on activated T cells exclusively in the presence of PD-L1 express
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b6a67af6d3feb804d4ee90255eb63e4
https://doi.org/10.1158/1538-7445.am2023-3579
https://doi.org/10.1158/1538-7445.am2023-3579
Autor:
Pim P. van de Donk, Lotte M. Smit, Joyce van Sluis, Wim Timens, Adrienne H. Brouwers, Marjolijn N. Lub- de Hooge, Sjoerd G. Elias, Jourik A. Gietema, Claudia A. van Winkel, JuAn Wang, Jason Giurleo, Thomas Uldrick, Hung Kam Cheung, Hilde Jalving, Sjoukje F. Oosting, Daan G. Knapen, Derk-Jan A. de Groot, Elisabeth G. de Vries
Publikováno v:
Cancer Research. 83:5611-5611
Background Immune checkpoint inhibitors (ICIs) can induce durable responses in multiple different tumor types. Lymphocyte activation gene-3 (LAG-3) is one of the immune checkpoints for which therapeutic antibodies are being developed. PET imaging wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::850640f5c1c72bc2b211c4d5efa4a87a
https://doi.org/10.1158/1538-7445.am2023-5611
https://doi.org/10.1158/1538-7445.am2023-5611